Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists.

MLA

Evers, Andreas, et al. “Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists.” Journal of Medicinal Chemistry, vol. 60, no. 10, May 2017, pp. 4293–303. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.7b00174.

APA

Evers, A., Haack, T., Lorenz, M., Bossart, M., Elvert, R., Henkel, B., Stengelin, S., Kurz, M., Glien, M., Dudda, A., Lorenz, K., Kadereit, D., & Wagner, M. (2017). Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists. Journal of Medicinal Chemistry, 60(10), 4293–4303. https://doi.org/10.1021/acs.jmedchem.7b00174

Chicago

Evers, Andreas, Torsten Haack, Martin Lorenz, Martin Bossart, Ralf Elvert, Bernd Henkel, Siegfried Stengelin, et al. 2017. “Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists.” Journal of Medicinal Chemistry 60 (10): 4293–4303. doi:10.1021/acs.jmedchem.7b00174.